I am Medical Doctor and Specialist in Infectious and Tropical Diseases with further training on Clinical Epidemiology, with long-track record of research and the provision of healthcare services for the prevention, diagnosis and treatment of HIV infection, tuberculosis (TB), specifically multidrug and extensively drug-resistant (MDR/XDR) TB, and HIV/TB co-infection. I have a background in operational research, clinical trials, and implementation science in all the fields described before.
During 2007-2009, I was appointed as the Head of the National Laboratory for Mycobacteria Diagnosis at the Peru National Institute of Health. During that time, and with Peruvian government funding and grants from World Bank and Wellcome Trust Foundation, I led the implementation and scale up Genotype® MTDRplus (Hainlife Science, Neren Germany) and MODS (Microscopic Observation Drug Susceptibility) assays for the rapid detection of MDR-TB in different regions in Peru. Also, through a grant received from the International Association of National Public Health Institutes, we described the molecular epidemiology of extensive drug resistance cases diagnosed between 2005 and 2009 in Peru.
From 2011 and 2012, I led the Infectious Diseases Team for the Health Quality Project funded by USAID PERU to support the diagnosis, prevention and treatment policies of the National TB and HIV Control Programs in Peru. In 2011, I was awarded as fellow of the International Operational Research Course of the International Union of Tuberculosis and Lung Diseases (The Union), Paris, France, to investigate the impact of the implementation of the MODS assay in Peru. During 2012-September 2014, I worked at the National TB Control Program in Peru, as the Coordinator of the Investigation and Policy Elaboration Unit, which led the elaboration of the current Peruvian healthcare guidelines to control the HIV/TB co-infection in the country. In October 2014, I was appointed as Clinical Investigator at the IMPACTA PERU CTU to lead the implementation of study protocols funded by US NIH/NIAID/DAIDS. Since 2013, I have worked as temporary advisor of Pan-American Health Organization (PAHO) in tuberculosis and professor of The Union for TB, HIV and Operational Research (OR) for Latin-American countries. Currently, I have continued providing my support to the Peru National TB Control Program as a Consultant and Advisor control the HIV/TB epidemic. Finally, since 2016, I am a member of The Tuberculosis Transformative Science Group (TB TSG) of AIDS Clinical Trial Group (ACTG) from DAIDS/NIH and a member of the Tuberculosis Laboratory Diagnostics Working Group from HIV/AIDS Network Coordination (HANC).